ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2021)
Historic Income from Continuing Operations for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' Income from Continuing Operations fell 3793.68% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 421.52%. This contributed to the annual value of -$11.5 million for FY2024, which is 1439.03% down from last year.
- According to the latest figures from Q4 2021, ENDRA Life Sciences' Income from Continuing Operations is -$3.1 million, which was down 3793.68% from -$2.7 million recorded in Q3 2021.
- ENDRA Life Sciences' Income from Continuing Operations' 5-year high stood at -$741623.0 during Q1 2017, with a 5-year trough of -$4.8 million in Q4 2019.
- Its 5-year average for Income from Continuing Operations is -$2.6 million, with a median of -$2.7 million in 2019.
- In the last 5 years, ENDRA Life Sciences' Income from Continuing Operations crashed by 28096.22% in 2018 and then soared by 5319.98% in 2020.
- ENDRA Life Sciences' Income from Continuing Operations (Quarter) stood at -$2.3 million in 2017, then decreased by 3.09% to -$2.4 million in 2018, then plummeted by 103.3% to -$4.8 million in 2019, then soared by 53.2% to -$2.3 million in 2020, then crashed by 37.94% to -$3.1 million in 2021.
- Its last three reported values are -$3.1 million in Q4 2021, -$2.7 million for Q3 2021, and -$3.2 million during Q2 2021.